ENOV ENOVIS CORPORATION

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on  in the “Investors” section.

Conference call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit .

Contact:

Kyle Rose

Vice President, Investor Relations

Enovis Corporation





EN
17/04/2024

Underlying

ENOVENOVIS CORPORATION

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ENOVIS CORPORATION

 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces First Quarter 2024 Results

Enovis Announces First Quarter 2024 Results Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansionReported first-quarter net loss from continuing operations of $1.32 per share with adjusted earnings per diluted share of $0.50 Wilmington, DE, May 02, 2024 (GLOBE NEWSWIRE) --   Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended March 29, 2024. The Company will host an investor conference call and live webcast to discuss these...

May 2, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on  in the “Investors” section. Conference call/Webcast Information Investors can a...

April 17, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Co...

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024. A link to the live audio webcast, as well as a replay of this event, will be available on the Company’s website under the Investors...

March 28, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces Fourth Quarter and Full Year 2023 Results

Enovis Announces Fourth Quarter and Full Year 2023 Results Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per diluted share of $0.79Entering 2024 with strong operating momentum and an exciting slate of new product launches Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended ...

February 22, 2024 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Co...

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024. In addition, the Company will present itself as a newly integrated company following the acquisition of orthopedic leader LimaCorporate S.p.A (“Lima”). “Enovis has a lot to be excited about in 2024. In o...

February 12, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch